Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

Leukemia

Volumn 14, Issue 5, 2000, Pages 796-804

  Schnittger, S ^a,d   Kinkelin, U ^a   Schoch, C ^b   Heinecke, A ^c   Haase, D ^a   Haferlach, T ^b   Buchner T ^c   Wormann B ^a   Hiddemann, W ^b   Griesinger, F ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

AML; MLL gene; Tandem duplication; Trisomy 11

Indexed keywords

CYTARABINE; DAUNORUBICIN; MITOXANTRONE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHILD; CHROMOSOME ABERRATION; CONTROLLED STUDY; EXON; GENE DUPLICATION; GENE TRANSLOCATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MARKER GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SOUTHERN BLOTTING; SURVIVAL RATE; TANDEM REPEAT; TRISOMY;

EID: 0034097609     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401773     Document Type: Article

References (38)

1. Bernard OA, Berger R. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromos Cancer 1995; 13: 75-85.
2. Nilson I, Löchner K, Siegler C, Greil J, Beck J, Fey G, Marschalek R. Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukemias. Br J Hematol 1996; 93: 966-972.
3. Drexler HG, Thiel E, Ludwig WD. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 1991; 5: 637-645.
4. Cuneo A, Michaux JL, Ferrant A, Van HL, Bosly A, Stul M, Dal CP, Vandenberghe E, Cassiman JJ, Negrini M et al. Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood 1992; 79: 720-727.
5. Kalwinsky DK, Raimondi SC, Schell MJ, Mirro JJ, Santana VM, Behm F, Dahl GV, Williams D. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 1990; 8: 75-83.
6. Martinez-Climent CJ, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R, Murphy SB, Vardiman JW, Larson RA, Le Beau M, Rowley JD. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995; 9: 95-101.
7. Fenaux P, Preudhomme C, Lai J, Morel P, Beuscart R, Bauters F. Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases. Br J Haematol 1989; 73: 61-67.
8. Mrozek K, Heinonen K, Lawrence D, Carroll AJ, Korduru PR, Rao KW, Strout MP, Hutchison RE, Moore JO, Mayer RJ, Schiffer CA, Bloomfield CD. Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: a Cancer and Leukemia Group B study. Blood 1997; 90: 4532-4538.
9. Baer MR, Stewart CC, Lawrence D, Arthur DC, Mrozek K, Strout MP, Davey FR, Schiffer CA, Bloomfield CD. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry. Leukemia 1998; 12: 317-325.
10. Caligiuri M, Schichman SA, Strout MP, Mrozek K, Baer MR, Frankel SR, Barcos M, Herzig GP, Croce CM, Bloomfield CD. Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Ses 1994; 54: 370-373.
11. Schichman SA, Caligiuri M, Strout M, Carter S, Gu Y, Canaani E, Bloomfield C. Croce C. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between ALU elements. Cancer Res 1994; 54: 4277-4280.
12. Schichman S, Caligiuri M, Gu Y, Strout M, Canaani E, Bloomfield C, Croce C. ALL-1 partial duplication in acute leukemia. PNAS 1994; 91: 6236-6239.
13. Takasaki N, Kaneko Y, Maseki N, Sakurai M. Trisomy 11 in chronic myelomonocytic leukemia: report of two cases and review of the literature. Cancer Genet Cytogenet 1988; 30: 109-117.
14. Weh HJ, Hoffmann R, Suciu S, Kuse R, Hossfeld DK. Is trisomy 11 another nonrandom chromosomal anomaly in acute nonlymphocytic leukemia and myelodysplastic syndromes? Cancer Genet Cytogenet 1988; 35: 205-211.
15. Ohyashiki K, Nagasu M, Hojo H, Iwabuchi A, Ohyashiki JH, Toyama K. Myelodysplastic syndrome with trisomy 11 associated with polycythemia vera. Am J Hematol 1989; 31: 122-125.
16. Avanzi GC, Giovinazzo B, Rosso A, Depaoli L, Bertini M, Resegotti L, Pegoraro L. Trisomy 11 in myelodysplastic syndrome-derived acute myeloblastic leukaemias. Eur J Haematol 1989; 43: 173-177.
17. Bilhou-Babera C, Lesesve J, Marit G, Lafarge M, Destugue N, Goullin B, Arnoulet C, Stoppa A-M, Muguet F, Attal M, Lacombe F, Braustet A, Reiffers J, Bernard P. Trisomy 11 in acute myeloid leukemia: ten cases. Leukemia 1994; 8: 2240-2231.
18. Slovak ML, Traweek ST, Willman CL, Head DR, Kopecky KJ, Magenis RE, Appelbaum FR, Forman SJ. Trisomy 11: an association with stem/progenitor cell immunophenotype. Br J Haematol 1995; 90: 266-273.
19. Caligiuri MA, Strout MP, Schichman SA, Mrozek K, Arthur DC, Herzig GP, Baer MR, Schiffer CA, Heinonen K, Knuutila S, Nousiainen T, Ruutu T, Block AW, Schulman P, Pedersen BJ, Croce CM, Bloomfield CD. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res 1996; 56: 1418-1425.
20. Bernard OA, Romana SP, Schichman SA, Mauchauffe M, Jonveaux P, Berger R. Partial duplication of HRX in acute leukemia with trisomy 11. Leukemia 1995; 9: 1487-1490.
21. Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F, Knuutila S, Mrozek K, Oberkircher AR, Marcucci G, de la Chapelle A, Elonen E, Block AW, Rao PN, Herzig GP, Powell BL, Ruutu T, Schiffer CA, Bloomfield CD. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998; 58: 55-59.
22. Schichman S, Canaani E, Croce C. Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia. JAMA 1995; 273: 571-576.
23. Yu M, Honoki K, Andersen J, Paietta E, Nam DK, Yunis JJ. MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia 1996; 10: 774-780.
24. Rowley JD. Rearrangements involving chromosome band 11q23 in acute leukaemia. Semin Cancer Biol 1993; 4: 377-385.
25. Bennett J, Catovsky D, Daniel M-T, Flandrin G, Galton D, Gralnick H, Sultan C. Proposals for the classification of acute leukemias, a report of the French-American-British Cooperative Group. Br J Haematol 1976; 33: 451-458.
26. Bennett J, Catovsky D, Daniel M-T, Flandrin G, Galton D, Gralnick H, Sultan C. Criteria for the diagnosis of acute leukemias of megakaryocyte lineage (M7), a report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 460-462.
27. Büchner T, Hiddemann W, Wörmann B. Intensive consolidation versus prolonged maintenance following intensive induction and conventional consolidation in primary AML: a study by AMLCG. Blood 1996; 88 (Suppl 1): 214A.
28. ISCN. Guidelines for Cancer Cytogenetics. Karger: Basel, 1995.
29. Miller S. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acid Res 1988; 16: 1215-1216.
30. Schnittger S, Wörmann B, Hiddemann W, Griesinger F. Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood 1998; 92: 1728-1734.
31. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce C, Canaani E. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to drosophila trithorax to the AF-4 gene. Cell 1992; 71: 701-708.
32. Kaplan E, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
33. Yamamoto K, Hamaguchi H, Nagata K, Kobaqashi M, Taniwaki M. Tandem duplication of the MLL gene in myelodysplastic syndrome-derived overt leukemia with trisomy 11. Am J Hematol 1997; 55:41-45.
34. Kwong Y. Partial duplication of the MLL gene in acute myelogenous leukemia without karyotypic aberration. Cancer Genet Cytogenet 1997; 97: 20-24.
35. So CW, Ma ZG, Price CM, Dong S, Chen SJ, Gu LJ, So CK, Wiedemann LM, Chan LC. MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. Cancer Res 1997; 57: 117-122.
36. Strout M, Marcucci G, Bloomfield C, Caligiuri M. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alumediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci USA 1998; 95: 2390-2395.
37. Bloomfield C, Lawrence D, Byrd J, Carroll A, Pettenati M, Tantravahi R, Patil S, Davey F, Berg D, Schiffer C, Arthur D, Mayer R. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 1998; 58: 4173-4179.
38. Schlenk R, Fischer K, Del Valle F, Harmann F, Pralle H, Fischer J, Gunzer U, Pezzutto A, Weber W, Grimminger W, Preiss J, Göckel F, Haase R, Dohner H. Stratification of postremission therapy in adult acute myeloid leukemia according to the karyotype -preliminary results of a multicenter treatment trial AML HD93. In: Hiddemann W, Büchner T, Wörmann B, Ritter J, Creutzig U, Keating M, Plunkett W (eds). Acute Leukemias VII: Experimental Approaches and Novel Therapies. Springer: Berlin, 1998, pp 867-876.